China has developed its first erectile dysfunction treatment based on the compound ingredient previously patented for Viagra.
Shanghai-based Guangzhou Baiyuanshan Pharmaceutical Holdings will sell Jin'ge, which translates to "Golden Spear," for under $8 per pack - 60% less than Pfizer charges for Viagra in China.
Pfizer's patent for Viagra in China expired in May.
According to in-pharmatechnologist, GBPH will produce the pills using the quality by design concept, and has developed its own synthesis routes for the API in compliance with U.S. and European Pharmacopoeias guidance.
Read the China Daily story.
